Skip to contentC
CareDx, Inc.
C
CDNACareDx, Inc. Q3 2024 · 10-Q
Revenue$82.88M$82.88M+23.4% vs Q3 2023 Net Income-$10.64M-$10.64MN/M vs Q3 2023 EPS Diluted-$0.20-$0.20N/M vs Q3 2023 Operating Income-$13,721,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-16.6%+26.3 pt vs Q3 2023
Net margin-12.8%+22.1 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 4, 2024 · 35 d after period end